Na,K-ATPase activity and isoform expression were measured in rat small intestinal mucosa taken from both normal and streptozocin-treated diabetic rats. Enzyme activity and abundance was 1.7-23-fold higher in rats diabetic for 2 wk than in controls. This was associated with 1. 
Introduction
Na,K-ATPase consists of a catalytic a subunit ( 111. 7-112.6 kD) and a glycosylated # subunit (32-34 kD, core protein).
Three isoforms of the a subunit (a 1, a2, and a3) have been identified ( 1, 2) . Their genes are located on different chromosomes and are expressed in a cell and tissue-specific manner (3, 4) : a1 has been identified in virtually all tissues, a2 in the brain, heart, and skeletal muscle, and a3 in brain, heart, ciliary epithelium, and leukocytes (3, 5, 6) . Rat small intestine has recently been shown to express only the a 1 isoform (7, 8) , as had previously been shown for rat kidney (2) . The mRNA levels for a and ,B1 in the small intestine are considerably lower at birth than in adult rats and are increased by glucocorticoids (8) . Similar results were obtained for rat colon (10) . Four isoforms of the subunit have also been described in various tissues (2, 3, 5, 9, (11) (12) (13) (14) (15) . The ,3 subunit contributes to localization of newly synthesized a subunit molecules and also protects it from hydrolytic breakdown ( 14, 15 ).
In rats with experimental or spontaneous diabetes, maximal NaK-ATPase activity has been reported to be decreased in heart, retina, peripheral nerve, kidney glomeruli, and skeletal muscle (16) (17) (18) (19) (20) but to be increased in kidney tubules and intestines (21, 22) . Experimental diabetes in rats also results in increased intestinal length, perimeter, wet and dry weight, villus height, and crypt depth (23) (24) (25) (26) . There are also increases in Na-dependent sugar, amino acid, and bile acid absorption in the ileum (25, (27) (28) (29) (30) (31) (32) , and in the number of Na-dependent glucose carriers in ileal brush border membranes (32) .
In this study of rat small intestinal mucosa, we have examined the expression of specific isoforms of Na,K-ATPase at both protein and mRNA levels and have explored the changes which occur in experimental diabetes and with administration of glucagon.
Methods
Animal preparation. Male Sprague Dawley rats were obtained from Charles River Labs (Wilmington, MA). Diabetic and age-matched control rats were housed in a light-cycled animal care facility and given ad lib access to water and regular chow. Diabetes was induced by an intraperitoneal injection of 75 mg/kg streptozocin. This dose resulted in a serum glucose level of > 300 mg/dl in 80% of rats within 24 h of injection; the remaining 20% were not used in this study. One group of diabetic rats was treated for 2-3 wk beginning 24 h after the streptozocin injection with a daily subcutaneous injection (2-8 U) of neutral protamine hagedorn (NPH) insulin. This dose was adjusted to maintain the blood sugar < 130 mg/dl. One group of normal rats was treated daily for 14-18 d with 80 ag/kg glucagon i.p. every 6 h.
Rats were sacrificed by decapitation after mild CO2 narcosis. The small intestines were removed from the ligament ofTreitz to the ileocecaljunction, flushed with ice-cold 2 M NaCl and cut along the anti-mesenteric border. Small intestinal mucosae of diabetic and age matched control rats were then scraped into ice cold 2 M NaCl, washed three times with 50 mM tris 5 mM EDTA, pH 7.2, and two times with 50 mM Tris 1 mM EDTA, pH 7.2, and homogenized at 4°C in 250 mM sucrose, 30 mM histidine, and 1 mM EGTA buffer, pH 7.2. The use of hypertonic followed by hypotonic salt solutions was previously shown to loosen the mucocalyx and remove mucus from toad bladder epithelium, rendering Na,K-ATPase measurement far more accurate (33) . Microsomal membranes were prepared as described by Cortas et al. (34) . In some experiments sodium deoxycholate was added to the mucosal homogenate to a final concentration of 0.1% (0.48±0.06 mg DOC/mg protein).
Na,K-ATPase assays. Assays were done at 37°C in the presence of 130 mM NaCl, 20 mM KC1, 5 mM MgCI2, 3 mM NaN3, 3 mM ATP, and 30 mM Tris, pH 7.2, as previously described (33) . After equalization ofthe ouabain concentration in all tubes, the amount ofphosphate released was measured by a modification ofthe method ofBaginski and Zak (35) ; 2% ammonium molybdate was added instead of 1% followed within 10 s by 2% arsenite-4% citrate-2% glacial acetic acid. ence of 0.1-0.4 mg sodium dodecyl sulphate (SDS) or 1 mg sodium deoxycholate (DOC) per milligram of protein.
For ouabain inhibition curves, total homogenate or microsomal membranes were incubated for 3 h in the presence of varying concentrations of ouabain and 0.1-0.2 mg SDS/mg protein, required to stabilize the enzyme preparations. Omission ofthe detergent resulted in loss of up to 70% of Na,K-ATPase activity in 3 h whether or not antiproteases were added.
Alkaline phosphatase was assayed in the presence of 100 mM tris, 5 mM MgCl and 0.1 mM ZnCl2, pH 10.5, as previously described (36) .
DNA was determined on perchloric acid extracts of total homogenate as previously described (37, 38). RNA was measured as in Maniatis et al. (39) and protein by the method of Lowry et al. (40) .
Ouabain-stimulated phosphorylation of Na,K-ATPase by orthophosphate ("back door phosphorylation"). To quantitate the number of Na pump molecules, Na,K-ATPase was phosphorylated with orthophosphate (back door phosphorylation) as previously described (41, 42) . Briefly, SDS-treated microsomal membranes were incubated at room temperature for 30 min in the presence ofvarious concentrations of phosphate , SDS (0.1-0.2 mg/mg protein) with or without 4 mM ouabain. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] MCi of carrier-free 32P-orthophosphate was then added (to reduce the presence of pyrophosphates and background radioactivity, the 32P-orthophosphate was preincubated with bovine kidney microsomes at 37°C for 30 min followed by filtration through a 0.22-,MM filter and boiling for 3 min). The reaction was quenched 30 min later with 10% BSA and 20% TCA in 0.1 mM H3PO4. The 12,000-g TCA pellets were washed with the same solution 3-5 times, dissolved in 300 Ml of0.1 N NaOH and 10% SDS, transferred to a specific volume of Ultima Gold scintillant fluid and counted in a Beckman scintillation counter (Beckman Instruments, Inc., Fullerton, CA). The 32P bound to boiled microsomes was subtracted as background radioactivity. Ouabain-stimulated binding of phosphate (specific to Na,K-ATPase) represented the difference between binding in the presence of ouabain and in its absence. I mole of Pi in this assay binds to 1 mole of Na,K-ATPase. After subtracting background radioactivity, 60-85% of the signal is ouabain stimulated. Pump abundance, defined as the concentration of pumps per milligram of protein, was calculated and expressed in nanomoles of Na,K-ATPase per mg protein.
Immunoblot analysis. Partially purified enzyme was prepared according to the method of Jorgenson (43) Northern blot analysis. Small intestinal mucosa was scraped and immediately frozen in liquid nitrogen. Total cellular RNA was prepared by the methods of Chirgwin et al. (44) . Equal amounts of total RNA extracted from control and diabetic rats (20 Mg per lane) were fractionated in a 1% agarose-6% formaldehyde lx MOPS gel, blotted on nitrocellulose, and probed with cDNA for al, a2, a3, # 1, and B2 labeled with 32p by nick translation as per Russo et al. (45) . Autoradiograms were quantitated by densitometry.
Statistical analysis. Curve fitting and statistical analyses were performed by BMDPAR, a derivative-free nonlinear regression software package developed at the University of California (Los Angeles, CA) and converted for use on Dec Vax-1 I by Management Science Associates (Pittsburgh, PA).
Results
Mucosal mass, protein, and DNA. 64 of 76 rats injected with streptozocin had blood glucoses above 300 mg/dl (compared to 103±4 mg/dl in vehicle-treated controls) and were used for this study. Table I shows that, after 6-8 wk of diabetes, the mean final body weight (Wf) of the streptozocin-treated rats (D3) had decreased by an average of 33% while that of agematched controls (C3) had increased by 14%. In contrast, total protein and DNA contents in the small intestines of diabetic rats were 1.26-1.47 times greater than in controls (Table I) . The length and mucosal wet weight of the small intestine also increased; at the end of 2 wk, lengths were 123±1 and 148±1 cm and mucosal wet weights were 4.9±0.5 and 7.0±0.1 g, in control and diabetic rats respectively (P < .05 for both differences). Results at 6-8 wk were similar. Insulin treatment ofthe streptozocin-treated rats prevented all these changes (Table I) . There was no difference in the protein/DNA ratio between control, diabetic and insulin-treated diabetic rats.
Na,K-ATPase activity. Na,K-ATPase activity in intestinal mucosal homogenates increased 1.7-2.3-fold within 2 wk of the onset of diabetes and remained constant thereafter (Table  II) . This was true whether measured per milligram of protein or per milligram of DNA. The changes were of a comparable relative magnitude in detergent-treated and in nondetergenttreated homogenates. Results were similar for Na,K-ATPase activity measured in microsomal membranes (Table III) . The time course for this increase is shown in Fig. 1 . The first statistically significant increase in enzyme activity was seen at 6 d after streptozocin injection. Mg-ATPase and alkaline phosphatase activities in homogenates of control and diabetic rats did not differ significantly (Table III) .
NPH insulin (2-8 U) administered daily for 2-3 wk to rats beginning 24 h after streptozocin injection, maintained the blood sugar below 130 mg/dl for at least two thirds ofthe study period and prevented the increase in Na,K-ATPase activity otherwise seen (Table II) .
To determine whether the increase in Na,K-ATPase activity seen in diabetes resulted from an increase in pump abundance or from an increase in pump turnover number, the concentration of Na/K pumps in intestinal microsomal mem- branes was measured by "back door" phosphorylation. As shown in Table III , diabetes caused a 2.5-fold increase in pump abundance, almost completely accounting for the increase in Na,K-ATPase activity. Na/K pump turnover did not change significantly.
To determine whether diabetes alters the affinity of small intestinal Na,K-ATPase for Na+, mucosal homogenate enzyme activity was determined in 1 5-min assays at varying concentrations of Na+ in the absence of detergent. There was no difference in the determined Kms for Na+ (14.9±1.2 mM in control rats [n = 4] vs 13.1±1.8 mM in diabetic rats [n = 4]).
Alpha isoforms of Na,K-ATPase are known to differ in their sensitivity to inhibition by ouabain (2) . To determine if enzyme molecules with more than one sensitivity to inhibition by ouabain are expressed in normal or diabetic small intestinal mucosa, Na,K-ATPase activities in homogenates and microsomal membranes from control and diabetic rats were measured at different concentrations of ouabain. As shown in Immunoblots. Immunoblots with anti-al, a2, and a3 monospecific antibodies were initially performed on protein from mucosal homogenates and microsomal membranes from diabetic and control rats. The signal to noise ratio was too low for interpretation. We therefore partially purified the Na,K-ATPase in microsomal membranes by SDS treatment followed by centrifugation through glycerol gradient (34) . These preparations showed sevenfold (120±19 ,um) and 10-fold (94±9.5 ,um) increases in enzyme specific activity for diabetic and control rats, respectively. SDS-PAGE analyses (34, 46) of these preparations demonstrated enrichment of the 92.5-kD band representing the a subunit(s) of Na,K-ATPase, as compared with untreated microsomal membranes (Fig. 3) . The identity ofthis band was confirmed by immunoblot analysis. As shown in Fig. 4, a 1 but not a2 or a3 were detected, as was also 31. The sensitivity of the antibody probes for a2 and a3 was checked on immunoblots containing different amounts ofpartially purified brain (al, a2, and A3), kidney (a 1) and intestinal mucosa (a 1) Na,K-ATPase preparations. In the brain, al, a2, and a3 are equal in abundance. The minimum amounts ofNa,K-ATPase required for detection ofa 1, a2, and a3 in the brain and a 1 in intestinal mucosa were equivalent and ranged from 0.035-0.045 U of Na,K-ATPase activity. Anti-a2 and anti-a3 antibodies did not cross react with the a 1 subunit in the kidney preparation. To avoid anomalous mobility ofthe bands on SDS-PAGE (34), we could maximally load 10 U of partially purified small intestinal Na,K-ATPase for immunoblot analysis. a 1 was clearly detected but not a2. Hence a2, if present at all, would be < 0.5% of al . The same was true for a3. Immunoblot analysis after labeling with I25I-strepavidin and autoradiography also demonstrated that the increased Na,K-ATPase activity with diabetes is associated with increased abundance of a 1 and 13 subunits. Enzyme abundance was measured by densitometric scanning of the autoradiograms. A constant Na,K-ATPase activity to abundance ratio was obtained for both control and diabetic preparations, indicating again similar turnover numbers.
Northern blots. To determine whether the increase in Na,K-ATPase activity and a 1 and 11 abundances seen with diabetes are associated with increases in mRNA encoding these subunits, Northern blots oftotal RNA were probed with 32P-labeled cDNA a 1, a2, a3, and 131. Quantitation (48, 49) . It is also associated with increases in serum concentrations of mineralocorticoids and glucocorticoids, a decrease in serum concentrations of thyroid hormones, an increase in serum [K+], Figure 6 . Detection of mRNAO1. Autoradiograms of Northern blots of and a decrease in total body K+ (50, 51 tissues studied (52) . Hypothyroidism decreases NaK-ATPase from diabetic rats; and lanes 9 and 10 from rats treated with glucagon in the gut (53) . Mineralocorticoid receptors appear to be presfor 2 wk.
ent in the colon but not in the small intestine (54, 55) . The increased Na,K-ATPase activity occurring in the proximal Discussion convoluted tubules (PCT) and medullary thick ascending limb of Henle's loop (MAL) with diabetes was not prevented by Streptozocin-induced diabetes in the rat results in increases in adrenalectomy although that occurring in the cortical convosmall intestinal mucosal mass, protein and DNA contents, imluted tubules (CCT) was prevented (50) . In rat small intestine, plying an increase in the total number of intestinal epithelial a very high dose of hydrocortisone increased Na,K-ATPase by cells. These became maximal within 2 wk and remained essen-30%, which is only a small fraction of the increase in tially constant thereafter. These findings are in agreement with NaK-ATPase measured in the same study in streptozocin-inhistologic studies showing significant intestinal mucosal hyper-duced diabetes (56) . High doses of other glucocorticoids have trophy and hyperplasia in rats with diabetes (23) (24) (25) (26) . This hyalso been shown to increase Na,K-ATPase activity in rat small perplasia is also seen in renal tubules (21, 47) but not in a intestine (9, 57, 58) . As for K+, only extreme changes incomnumber of other organs tested. patible with life have been shown in vitro to induce new syntheSimilarly, increases in intestinal mucosal Na,K-ATPase acsis of Na,K-ATPase (59). tivity and abundance were maximal within 2 wk. This change Glucagon, on the other hand, was shown in the present in enzyme activity was preceded by coordinate increases in study to cause a marked increase in mRNA.1 but not mRNA1,.
mRNA encoding the a 1 and (31 subunits ofNa,K-ATPase. The The increase in mRNAai was similar in magnitude to that seen increase in enzyme activity was detectable by the third day of with diabetes. Measurements ofintestinal enzyme activity after diabetes and became statistically significant by the sixth day.
glucagon administration revealed no increase in enzyme activAn increase in Na,K-ATPase activity with diabetes was previ-ity, however. The determinants that upregulate the (l3 subunit ously reported in renal tubules but not glomeruli (21, 47) and in diabetes need to be further investigated. A prior study demin rat intestinal mucosa (22) although in neither case were its onstrated that the sensitivity of rat ileal transepithelial Na' time course and transcriptional regulation determined. Hence, transport to inhibition by ouabain is decreased in experimental the two tissues, (small intestinal mucosa and renal tubule) diabetes and that this effect could be mimicked by the in vitro whose mass increased with diabetes were also those in which addition of glucagon (60) . The relation of those effects to the the specific activity of Na,K-ATPase increased. The twofold present findings is uncertain but could involve synthesis and increase in mRNA encoding Na,K-ATPase seen 24 h after basolateral membrane localization of new enzyme. streptozocin injection most likely preceded the onset of muco-
We are not aware of measurements of intestinal sal cell proliferation. Thymidine uptake studies are needed to Na,K-ATPase in diabetic humans. In several other respects, confirm this.
however, intestinal changes in streptozocin-induced diabetes In contrast to the intestinal mucosa and renal tubules, in the rat have been shown to mimic the human disease. This is Na,K-ATPase activity decreased with diabetes in the heart true for the observed mucosal hypertrophy (61 ) , for the appear-( 17), neural tissues ( 19, 20) , and skeletal muscle ( 16) . These ance of autonomic neuropathy (62) for the enhancement of decreases were seen in the absence of significant changes in the absorptive processes for sugar and amino acids (63) , and tissue mass, protein and DNA contents.
for increases in circulating levels of glucagon (48, 49) . Three isoforms (a 1, a2, and a3) of the catalytic subunit of Studies in liver epithelial cells by Koch and Leffert (64) and Na,K-ATPase have been detected in adult rat heart and brain in 3T3 fibroblasts by Smith and Rozengurt (65) suggest a relabut only one isoform (a I ) in adult rat kidney (2, 34) ; as in the tionship between glucagon, Na,K-ATPase and cell proliferalatter tissue, only the a 1 isoform, has been detected in small tion. Trophic hormones such as glucagon, insulin and EGF intestinal mucosa (7, 8) . The present study shows this to be were found to produce a short term ( 1-2 h) effect in which true for both diabetic and control small intestinal mucosa as Na,K-ATPase activity increases in response to enhanced soevidenced by: (a) monophasic ouabain inhibition curves, (b) dium influx and a long term (6-48 h) effect involving new immunoblot analysis of the partially purified enzyme, and(c) protein synthesis in which NaK-ATPase activity and abunNorthern blot analysis of total intestinal mucosal RNA. At dance, as well as sugar and amino acid transports, increases. functional, protein, and mRNA levels, therefore, evidence was These changes were associated with ouabain-inhibitable inDiabetes, Glucagon, and Intestinal Na,K-ATPase 2729 creases in DNA synthesis and cell proliferation (64) (65) (66) (67) (68) . Increased NaK-ATPase mRNA91 subunit abundance preceded hepatic epithelial cell proliferation (69) . A possible physiologic role of the increased Na,K-ATPase activity seen in diabetes in the small intestine, liver, and kidneys is to facilitate the also observed increases in Na'-dependent solute transport (27).
